Kyle M. Hurth, MD, PhD

Associate Professor of Clinical Pathology

Program Director, Neuropathology Fellowship Program

Immunohistochemistry Laboratory Director

Is this your profile? Click to edit

Publications

Single cell and spatial sequencing analysis of cancer associated fibroblasts in the brain metastasis tumor microenvironment. Commun Biol. 2026 Apr 01; 9(1).. View in PubMed
Evidence for cPLA2 activation in Alzheimer’s disease synaptic pathology. Acta Neuropathol Commun. 2026 02 12; 14(1).. View in PubMed
A novel case of compound heterozygous GFPT1 congenital myasthenic syndrome with a coexisting heterozygous DYSF mutation: clinical and pathological insights. Neurol Sci. 2026 Jan 17; 47(1):170.. View in PubMed
Sex and Age Differences in Transcription Factor and Hormonal Immunostaining in Patients With Nonfunctioning Pituitary Adenomas. Oper Neurosurg. 2026 Jan 15.. View in PubMed
Multiparametric Dynamic Contrast Imaging for Voxelwise Quantitative Assessment of Brain Tumors. Radiol Imaging Cancer. 2025 09; 7(5):e250049.. View in PubMed
Multifocal intra-cranial masses: Late presentation of an uncommon histiocytic disorder. Radiol Case Rep. 2025 Nov; 20(11):5610-5614.. View in PubMed
Resolving spatial subclonal genomic heterogeneity of loss of heterozygosity and extrachromosomal DNA in gliomas. Nat Commun. 2025 Jun 13; 16(1):5290.. View in PubMed
Evidence for cPLA2 activation in Alzheimer’s Disease Synaptic Pathology. bioRxiv. 2025 Apr 01.. View in PubMed
A contemporary, multiinstitutional analysis of transcription factor lineage in pituitary adenomas: comparative study of neuroimaging, histopathology, and clinical outcomes. J Neurosurg. 2025 Jul 01; 143(1):146-154.. View in PubMed
The role of plasma metagenomic sequencing in identification of Balamuthia mandrillaris encephalitis. Acta Neuropathol Commun. 2025 03 13; 13(1):60.. View in PubMed

Kyle M. Hurth, MD, PhD

Publications

Similar People